HELS - ETF AI Analysis
Top Page
Hedgeye 130/30 Equity ETF (HELS)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the largest positions, including well-known companies in energy, consumer, and media, have shown strong year-to-date gains that help support the fund.
Broad Sector Diversification
The ETF spreads its investments across many sectors such as energy, consumer, health care, industrials, and technology, which can help reduce the impact of weakness in any single industry.
Exposure to Defensive Areas
Meaningful allocations to consumer defensive and health care stocks can provide some stability during market downturns.
Negative Factors
Recent Weak Performance
The fund has delivered weak returns over the past month, three months, and year-to-date, which may concern investors looking for near-term strength.
High Expense Ratio
The ETF charges relatively high fees, which can eat into returns over time compared with lower-cost alternatives.
Heavy U.S. Concentration
With the vast majority of its assets in U.S. stocks and only small exposure to Canada and Switzerland, the fund offers limited geographic diversification.
HELS vs. SPDR S&P 500 ETF (SPY)
AUM24.84M
RegionNorth America
Expense Ratio0.70%
Beta0.12
IssuerHedgeye
Inception DateDec 10, 2025
Dividend Yield0.02%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume15,774
30 Day Avg. Volume23,189
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
25.73Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering52
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
HELS Summary
The Hedgeye 130/30 Equity ETF (HELS) is an actively managed fund that invests mainly in U.S. stocks across the whole market, from different sizes and sectors like energy, health care, and consumer companies. It follows a long–short “130/30” strategy, meaning it buys stocks the managers like and bets against stocks they expect to do poorly, aiming to beat the overall stock market over time. Well-known holdings include Netflix and Exxon Mobil. Someone might invest for growth and broad diversification in one fund. A key risk is that this complex strategy can be more volatile and can go up and down with the stock market.
How much will it cost me?This ETF has an expense ratio of 0.70%, which means you’ll pay about $7 per year for every $1,000 invested. That’s higher than the average ETF because it’s actively managed and uses a more complex 130/30 long-short strategy, which generally costs more to run than simple index-tracking funds.
What would affect this ETF?This ETF could benefit if the U.S. economy stays healthy, supporting technology, industrial, and consumer companies like Nvidia, UPS, and Marriott, and if active managers successfully pick winners and short weaker stocks in a changing market. On the other hand, a U.S. slowdown, higher interest rates hurting growth and cyclical sectors, or missteps in the long-short strategy could lead to weaker results, and new regulations or market stress could make short selling and active management more challenging.
HELS Top 10 Holdings
HELS is leaning into a U.S.-only mix of tech, consumer, and industrial names, with a few standout winners doing much of the heavy lifting. Apple is rising steadily and helps anchor the fund’s tech tilt, while Intel has been on a tear, giving the portfolio a strong semiconductor flavor. On the industrial side, GE Vernova is powering ahead, and CSX has been a steady engine for returns. Consumer names like Starbucks and Ross Stores are more mixed, occasionally losing steam and tempering some of those gains.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ― | 5.95% | $1.48M | ― | ― | ― | |
| ― | 5.10% | $1.27M | ― | ― | ― | |
| Apple | 2.94% | $730.77K | $4.51T | 49.68% | 79 Outperform | |
| Alphabet Class A | 2.88% | $714.60K | $4.45T | 112.19% | 85 Outperform | |
| CSX | 2.71% | $672.60K | $87.31B | 47.31% | 78 Outperform | |
| United Rentals | 2.64% | $656.20K | $66.89B | 51.10% | 73 Outperform | |
| UnitedHealth | 2.55% | $633.16K | $362.78B | 31.76% | 72 Outperform | |
| Jazz Pharmaceuticals | 2.52% | $626.08K | $14.97B | 107.42% | 64 Neutral | |
| Marvell | 2.40% | $595.52K | $230.48B | 317.78% | 76 Outperform | |
| Roku | 2.34% | $582.24K | $18.04B | 53.61% | 65 Neutral |
HELS Technical Analysis
Negative
―
Price Trends
23.77
Positive
24.42
Negative
Market Momentum
0.14
Positive
51.07
Neutral
39.65
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For HELS, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 24.33, equal to the 50-day MA of 23.77, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of 0.14 indicates Positive momentum. The RSI at 51.07 is Neutral, neither overbought nor oversold. The STOCH value of 39.65 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HELS.
HELS Peer Comparison
Comparison Results
Performance Comparison
HELS
Hedgeye 130/30 Equity ETF
24.22
-0.59
-2.38%
BAMD
Brookstone Dividend Stock ETF
―
―
―
YALL
God Bless America ETF
―
―
―
STNC
Stance Equity ESG Large Cap Core ETF
―
―
―
SOVF
Sovereign's Capital Flourish Fund
―
―
―
RFDA
RiverFront Dynamic US Dividend Advantage ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents